🕵️ Edgewise Therapeutics, Inc. ($EWTX)
SEC insider & ownership activity, last 12 months · CIK 1710072 · every row links its SEC filing
Insider buy and sell values were withheld pending verification over the last 12 months. Janus Henderson Group PLC added 4.7% → 5.5%. No red-flag 8-Ks in the window.
🚨 4 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Insider flow
1 buyer, value withheld pending verification (1 lots) · 6 sellers, value withheld pending verification (33 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Jonathan C. Fox | 1 | value withheld pending verification | 0 | – | Nov 11, 2025 |
| Alan J. Russell | 0 | – | 6 | value withheld pending verification | Aug 12, 2026 |
| Edris Badreddin | 0 | – | 5 | value withheld pending verification | Jan 21, 2026 |
| Joanne Donovan | 0 | – | 11 | value withheld pending verification | Aug 13, 2026 |
| Behrad Derakhshan | 0 | – | 4 | value withheld pending verification | Aug 12, 2026 |
| Kevin Koch | 0 | – | 3 | value withheld pending verification | Aug 12, 2026 |
| John R. Moore | 0 | – | 4 | value withheld pending verification | Aug 12, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 14.5% | 13D | May 9, 2025 | filing ↗ | |
| Orbimed Capital GP VI LLC | 14.1% | 13D | May 9, 2025 | filing ↗ | |
| Paradigm BioCapital Advisors LP | 9.5% | 13G | Aug 14, 2026 | filing ↗ | |
| Paradigm BioCapital Advisors GP LLC | 9.5% | 13G | Aug 14, 2026 | filing ↗ | |
| Senai Asefaw, M.D. | 9.5% | 13G | Aug 14, 2026 | filing ↗ | |
| Paradigm BioCapital International Fund Ltd. | 8.3% | 13G | Aug 14, 2026 | filing ↗ | |
| RA Capital Management, L.P. | 7.8% | 13G | Aug 14, 2026 | filing ↗ | |
| Peter Kolchinsky | 7.8% | 13G | Aug 14, 2026 | filing ↗ | |
| Rajeev Shah | 7.8% | 13G | Aug 14, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 7.8% | 13G | Aug 14, 2026 | filing ↗ | |
| BlackRock, Inc. | 5.5% | 13G | Jul 17, 2025 | filing ↗ | |
| Janus Henderson Group PLC | 5.5% | 13G | May 15, 2026 | filing ↗ | |
| FMR LLC | 5.1% | 13G | Aug 6, 2026 | filing ↗ | |
| Abigail P. Johnson | 5.1% | 13G | Aug 6, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Joanne Donovan | $127K | Aug 13, 2026 | filing ↗ |
| Alan J. Russell | $8.1M | Jul 1, 2026 | filing ↗ |
| Joanne Donovan | $1.6M | May 5, 2026 | filing ↗ |
| Joanne Donovan | $2.3M | Mar 27, 2026 | filing ↗ |
| Badreddin Edris | $3.4M | Jan 21, 2026 | filing ↗ |
| Robert Michael Carruthers | $5.2M | Jan 20, 2026 | filing ↗ |
| Robert Michael Carruthers | $4.8M | Jan 15, 2026 | filing ↗ |
| Robert Michael Carruthers | $3.0M | Dec 26, 2025 | filing ↗ |
| Robert Michael Carruthers | $1.6M | Nov 17, 2025 | filing ↗ |
| Alan J. Russell | $2.1M | Nov 12, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jul 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 4, 2026 | filing ↗ |
| Material agreement (1.01) | May 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 31, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Officer/director changes (5.02) | Nov 19, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 19, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 10, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |